Patents by Inventor Wynne Weston-Davies

Wynne Weston-Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Treating Myasthenia Gravis
    Publication number: 20200282018
    Abstract: The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation and in particular in the treatment of myasthenia gravis.
    Type: Application
    Filed: October 25, 2019
    Publication date: September 10, 2020
    Applicant: Volution Immuno Pharmaceuticals SA
    Inventors: John Hamer, Wynne Weston-Davies
  • EV576 For Use in the Treatment of Viral Infections of the Respiratory Tract
    Publication number: 20200155646
    Abstract: The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine ‘flu).
    Type: Application
    Filed: June 7, 2019
    Publication date: May 21, 2020
    Applicant: Volution Immuno Pharmaceuticals SA
    Inventor: Wynne Weston-Davies
  • EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT
    Publication number: 20170065677
    Abstract: The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu).
    Type: Application
    Filed: July 22, 2016
    Publication date: March 9, 2017
    Applicant: Volution Immuno Pharmaceuticals SA
    Inventor: Wynne Weston-Davies
  • EV576 for use in the treatment of viral infections of the respiratory tract
    Patent number: 9522171
    Abstract: The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu).
    Type: Grant
    Filed: January 2, 2015
    Date of Patent: December 20, 2016
    Assignee: Volution Immuno Pharmaceuticals SA
    Inventor: Wynne Weston-Davies
  • METHOD OF TREATING MYASTHENIA GRAVIS
    Publication number: 20160166640
    Abstract: The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation and in particular in the treatment of myasthenia gravis.
    Type: Application
    Filed: October 20, 2015
    Publication date: June 16, 2016
    Inventors: John Hamer, Wynne Weston-Davies
  • Method of treating myasthenia gravis
    Patent number: 9192648
    Abstract: The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation, and in particular in the treatment of myasthenia gravis.
    Type: Grant
    Filed: September 5, 2006
    Date of Patent: November 24, 2015
    Assignee: Volution Immuno Pharmaceuticals SA
    Inventors: John Hamer, Wynne Weston-Davies
  • EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT
    Publication number: 20150196619
    Abstract: The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu).
    Type: Application
    Filed: January 2, 2015
    Publication date: July 16, 2015
    Inventor: Wynne Weston-Davies
  • EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT
    Publication number: 20120283167
    Abstract: The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu).
    Type: Application
    Filed: January 10, 2011
    Publication date: November 8, 2012
    Inventor: Wynne Weston-Davies
  • HISTAMINE BINDING PROTEIN
    Publication number: 20110152171
    Abstract: The invention relates to histamine binding proteins. The invention also relates to the use of such histamine binding proteins in the treatment and prevention of diseases.
    Type: Application
    Filed: May 21, 2009
    Publication date: June 23, 2011
    Inventor: Wynne Weston-Davies
  • Method of Treating Myasthenia Gravis
    Publication number: 20090209459
    Abstract: The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation and in particular in the treatment of myasthenia gravis.
    Type: Application
    Filed: September 5, 2006
    Publication date: August 20, 2009
    Inventors: John Hamer, Wynne Weston-Davies
  • Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils
    Publication number: 20070249528
    Abstract: The invention relates to a novel method for the treatment of disease conditions that are mediated by neutrophil cells. The method involves the administration to a patient suffering from such a condition, a histamine binding compound in a therapeutically-effective amount.
    Type: Application
    Filed: April 1, 2004
    Publication date: October 25, 2007
    Inventor: Wynne Weston-Davies